AMGNvsBIIB
Amgen IncvsBiogen Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
Amgen Inc
$348.62
+6.70%
Biogen Inc
$187.88
+6.91%
60-day price, rebased to 100
Round-by-round
Valuation upside
-41.60% vs +7.40% to DCF fair value
Balance-sheet strength
Altman Z 1.78 vs 3.10
Fundamental quality
Piotroski 8.00 vs 6.00 (of 9)
Growth + margins
Rule-of-40 32.00 vs 23.00
60-day momentum
+1.97% vs +6.64% price return
Market-cap liquidity
$188.8B vs $25.8B
Verdict
Across6categories,the two names are evenly matched —3wins each. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy onAMGNorBIIB
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.